|4Feb 20, 4:06 PM ET

Flynn Sean C. 4

4 · Vericel Corp · Filed Feb 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Vericel (VCEL) CLO Sean Flynn Exercises RSUs; Shares Withheld for Taxes

What Happened Sean C. Flynn, Chief Legal Officer of Vericel Corporation (VCEL), had restricted stock units (RSUs) vest and convert into common shares on Feb 18, 2026, and concurrently had shares withheld to satisfy tax withholding. On Feb 18 Flynn acquired (via conversion) 3,000 and 2,325 shares from vested RSUs (derivative conversions). To cover withholding/tax liabilities he disposed of 1,490 shares at $36.82 per share ($54,862) and 1,030 shares at $37.41 per share ($38,532) — total withheld value ≈ $93,394. On Feb 19, Flynn was also granted 35,000 and 14,000 additional RSUs (total 49,000 RSUs) subject to future vesting.

Key Details

  • Dates: Feb 18–19, 2026 (filing date Feb 20, 2026). Filing appears timely for the reported dates.
  • Vesting/conversion entries (code M): 3,000 and 2,325 shares converted from RSUs on Feb 18, 2026 (RSUs convert at $0 exercise price).
  • Tax withholding/disposition (code F): 1,490 shares withheld at $36.82 (≈ $54,862); 1,030 shares withheld at $37.41 (≈ $38,532); total ≈ $93,394; these withheld shares satisfied tax withholding on vesting (footnote F3).
  • Grants (code A): 35,000 RSUs and 14,000 RSUs granted on Feb 19, 2026 (total 49,000 RSUs). Footnote F10: these RSUs begin vesting Feb 19, 2027 and vest annually through 2030.
  • RSU details: each RSU represents a contingent right to one share (F5); no expiration for this award type (F6).
  • Shares owned after the transactions are not specified in the provided filing excerpt.

Context These transactions reflect routine executive equity activity: vesting/conversion of RSUs and share withholding to cover tax obligations (not an open-market sale for cash). The new RSU grants are future compensation subject to multi-year vesting, so they are a forward-looking retention/compensation instrument rather than an immediate purchase. Transaction codes used: M = exercise/conversion of derivative (here, RSU conversion), F = payment of exercise price or tax liability (share withholding), A = grant/award.

Insider Transaction Report

Form 4
Period: 2026-02-18
Flynn Sean C.
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2026-02-18+3,0004,262 total
  • Tax Payment

    Common Stock

    [F3][F2]
    2026-02-18$36.82/sh1,490$54,8622,772 total
  • Exercise/Conversion

    Common Stock

    [F4][F2]
    2026-02-18+2,3255,097 total
  • Tax Payment

    Common Stock

    [F3][F2]
    2026-02-18$37.41/sh1,030$38,5324,067 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F5][F7][F1][F6]
    2026-02-18+3,0003,000 total
    Common Stock (3,000 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F5][F8][F4][F6]
    2026-02-18+2,3250 total
    Common Stock (2,325 underlying)
  • Award

    Stock Option (Right to Buy)

    [F9]
    2026-02-19+35,00035,000 total
    Exercise: $38.17Exp: 2036-02-19Common Stock (35,000 underlying)
  • Award

    Restricted Stock Unit

    [F4][F10][F6]
    2026-02-19+14,00014,000 total
    Common Stock (14,000 underlying)
Footnotes (10)
  • [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest on February 17, 2027.
  • [F10]These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 19, 2027. The remaining RSUs will vest in annual installments on February 19, 2028, February 19, 2029, and February 19, 2030, respectively.
  • [F2]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • [F3]These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.
  • [F4]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022.
  • [F5]Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
  • [F6]No expiration date for this type of award.
  • [F7]The Fair Market Value of the vested derivative securities is $36.82 per share.
  • [F8]The Fair Market Value of the vested derivative securities is $37.41 per share.
  • [F9]These options shall begin vesting on February 19, 2026 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
Signature
/s/ Sean Flynn|2026-02-20

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4